A carregar...
Direct Acting Anti-hepatitis C Virus Drugs: Clinical Pharmacology and Future Direction
Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver disease. The introduction of direct acting antiviral agents (DAAs) for its treatment represents a major advance in terms of sustained virologic response (SVR) rates and adverse effect profiles. Mechanistically, DAAs inhibi...
Na minha lista:
| Publicado no: | J Transl Int Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
De Gruyter Open
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490957/ https://ncbi.nlm.nih.gov/pubmed/28680834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/jtim-2017-0007 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|